| John Travis Howell, MD | |
|
7755 Hickman Rd, Urbandale, IA 50322-4511 | |
| (515) 440-0771 | |
| Not Available |
| Full Name | John Travis Howell |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 7755 Hickman Rd, Urbandale, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841213717 | NPI | - | NPPES |
| 3030700 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 19551 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| John Travis Howell, MD 3901 Patricia Dr, Urbandale, IA 50322-2103 Ph: (515) 276-5147 | John Travis Howell, MD 7755 Hickman Rd, Urbandale, IA 50322-4511 Ph: (515) 440-0771 |
News Archive
A landmark study of 22 million safety devices used in 61 French hospitals over a two-year period has confirmed the theory that passive, fully automatic safety devices offer significantly better protection against accidental needlestick injuries (NSIs) than early generation active safety technologies such as semi-automatic (push-button) devices or those with manually sliding shields or hinged caps.
Synlogic, Inc., a clinical-stage company applying synthetic biology to beneficial microbes to develop novel, living medicines, today announced the publication in Nature Communications of preclinical data supporting its first clinical immuno-oncology program, SYNB1891, which is being evaluated in Phase 1 clinical trial in patients with advanced solid tumors or lymphoma.
The results of a unique study from the University of Gothenburg, Sweden, show that personality has an impact on how likely people are to take their medication. This is the first major study of its kind to be published in the online journal PloS ONE.
A pair of studies at UCLA's Jonsson Cancer Center that takes laboratory science to the patients' bedside found that combining the molecularly targeted therapy Herceptin with a specific chemotherapy combination resulted in significant tumor response rates and longer relapse-free periods in women with an aggressive form of advanced breast cancer.
Researchers at Moffitt Cancer Center have conducted a clinical trial aimed at preventing graft vs. host disease (GVHD) in patients who have received hematopoietic (blood) cell transplants (HCT). The study, comparing the drug tacrolimus (TAC) in combination with either methotrexate (MTX ) or sirolimus (SIR), found that the sirolimus/tacrolimus (SIR/TAC) combination was more effective in preventing grades II-IV acute GVHD and moderate-severe chronic GVHD after allogeneic blood cell transplantation.
› Verified 8 days ago
Scott Thomas Hanson, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4003 Nw Urbandale Dr, Urbandale, IA 50322 Phone: 515-237-3985 Fax: 515-237-3994 | |
James Raymond Bell, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2901 86th St, Urbandale, IA 50322 Phone: 515-276-3406 Fax: 515-276-5141 | |
Wayne Belling, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 3403 159th St, Urbandale, IA 50323 Phone: 515-528-6682 | |
Dr. Shawn Spooner, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2901 86th St, Urbandale, IA 50322 Phone: 515-276-3406 | |
Audrey Porter, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2413 71st St, Urbandale, IA 50322 Phone: 515-278-9595 Fax: 515-278-2329 | |
Kimberley P Bauman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6200 Aurora Ave, Urbandale, IA 50322 Phone: 515-270-1177 Fax: 515-643-9361 | |
Andrew Joseph Mcmurray, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4323 Nw Urbandale Dr, Urbandale, IA 50322 Phone: 515-875-9190 Fax: 515-875-9202 |